Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
Ophthalmology, 08/26/09
Nguyen QD et al. – For patients with data available at 6 months, improvement of 3 lines or more occurred in 8 of 37 in group 1 compared with 0 of 38 in group 2 and 3 of 40 in group 3. Excess foveal thickness was reduced by 50%, 33%, and 45% in groups 1, 2, and 3, respectively. During a span of 6 months, ranibizumab injections by the current protocol had a
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09
Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09
Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Value of retinal examination in hypertensive encephalopathy
Journal of Human Hypertension, 11/03/09
Retinopathy of Prematurity
NeoReviews, 11/04/09
Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09
Article Search
Sponsor


See Latest Articles


